Data / Research funding / Celiac Disease
Celiac Disease: 38 NIH awards ($48.3M) to 22 organizations
38 NIH awards ($48.3M) in the NIH spending category Celiac Disease, to 22 organizations, read 2026-11-03. NIH fiscal years 2021 to 2025.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- Topic
- NIH spending category
Awards
38 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|---|---|---|---|---|---|---|---|
| Tissue destruction and healing in Celiac Disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $9,512,977 | September 15, 2022 | July 31, 2027 | JABRI, BANA | reporter.nih.gov |
| Evaluation of Novel Technologies to Improve Clinical Management of Celiac Disease: The GLUTECH Trial | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $4,185,542 | September 15, 2023 | June 30, 2028 | LEBWOHL, BENJAMIN | reporter.nih.gov |
| Role of Transglutaminase 2 in Celiac Sprue | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,463,787 | September 20, 2003 | April 30, 2026 | KHOSLA, CHAITAN | reporter.nih.gov |
| Innate and adaptive immunity in celiac disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,167,311 | September 9, 2005 | August 31, 2025 | JABRI, BANA | reporter.nih.gov |
| B cell-T cell crosstalk in celiac disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,120,614 | September 21, 2021 | July 31, 2026 | ABADIE, VALERIE | reporter.nih.gov |
| Gut Viral and Bacterial Associations with Celiac Disease in the TEDDY Cohort | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $1,980,716 | August 20, 2020 | June 30, 2025 | LLOYD, RICHARD E | reporter.nih.gov |
| A Clinical Study of Latiglutenase as a Treatment for Symptom Reduction for Celiac Disease | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $1,927,735 | March 8, 2019 | April 30, 2024 | SYAGE, JACK A. | reporter.nih.gov |
| The Environmental Triggers of Diabetes (TEDDY) in Sweden | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2022 | $1,819,239 | March 1, 2003 | December 31, 2024 | LERNMARK, AKE | reporter.nih.gov |
| Microbial and Host Factors in the Progression to Celiac Disease | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,770,140 | June 12, 2024 | April 30, 2029 | HOLTZ, LORI R | reporter.nih.gov |
| Localizing Pathogenically Relevant Transglutaminase 2 in Celiac Disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $1,755,274 | September 7, 2021 | June 30, 2026 | KHOSLA, CHAITAN | reporter.nih.gov |
| Celiac and inflammatory bowel diseases: functional post-GWAS approach | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,722,912 | August 19, 2024 | July 31, 2029 | TYCKO, BENJAMIN | reporter.nih.gov |
| Role of gut protists in celiac disease | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $1,649,112 | February 8, 2023 | January 31, 2028 | HINTERLEITNER, REINHARD | reporter.nih.gov |
| Viral infections and celiac disease pathogenesis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2022 | $1,353,092 | May 20, 2014 | April 30, 2024 | JABRI, BANA | reporter.nih.gov |
| Toward parsing gut microbiota-epithelium-immune metabolic crosstalk in Celiac Disease | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,164,554 | June 14, 2024 | April 30, 2029 | ZOMORRODI, ALI R | reporter.nih.gov |
| NanoDiscs for Immune Modulation in Celiac Disease | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $1,050,000 | September 19, 2025 | August 31, 2027 | DANIEL, WESTON | reporter.nih.gov |
| A Clinical Study of Latiglutenase as a Treatment for Type 1 Diabetics with Celiac Disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 | $933,572 | September 8, 2020 | July 31, 2023 | SYAGE, JACK A. | reporter.nih.gov |
| The Celiac Disease Genomic, Environmental, Microbiome, and Metabolomic (CD-GEMM) Prospective Cohort Study | NIH | National Institute of Allergy and Infectious Diseases | 2023 | $822,642 | September 1, 2023 | August 31, 2025 | FASANO, ALESSIO | reporter.nih.gov |
| A behavioral intervention to optimize self-management of celiac disease in adolescents | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $793,000 | September 27, 2021 | November 30, 2026 | COBURN, SHAYNA SKELLEY | reporter.nih.gov |
| Evaluation of Novel Technologies to Improve Clinical Management of Celiac Disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2022 | $779,594 | September 7, 2021 | August 31, 2023 | LEBWOHL, BENJAMIN | reporter.nih.gov |
| Confirmatory Double-Blind Placebo-Controlled Efficacy Trial of a Gluten-Free Diet in a Subgroup of Persons with Schizophrenia Who Have High Levels of IgG Anti-Gliadin Antibodies | NIH | National Institute of Mental Health | 2021 | $773,272 | August 1, 2017 | May 31, 2024 | KELLY, DEANNA L | reporter.nih.gov |
| Prospective Multi-Omic Analysis of At-Risk infants to Model Celiac Disease Pathogenesis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $766,762 | August 1, 2019 | November 30, 2024 | LEONARD, MAUREEN MICHELLE | reporter.nih.gov |
| A generic and immunological investigation of JAK-STAT in the pathogenesis of Celiac | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $661,824 | September 1, 2021 | April 30, 2026 | KONG, XIAO-FEI | reporter.nih.gov |
| SCREENING FOR TOLEROGENIC ADJUVANTS TO ENHANCE ANTIGEN SPECIFIC IMMUNOTHERAPY FOR CELIAC DISEASE. | NIH | National Institute of Allergy and Infectious Diseases | 2023 | $599,945 | September 30, 2023 | September 29, 2025 | CARGILL, CHRISTINA | reporter.nih.gov |
| Mechanisms and Markers of Small Intestinal Epithelial Injury and Villous Atrophy | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $580,119 | March 7, 2019 | February 28, 2025 | SILVESTER, JOCELYN ANNE | reporter.nih.gov |
| Computational Characterization of Environmental Enteropathy | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $577,656 | August 1, 2019 | May 31, 2024 | SYED, SANA | reporter.nih.gov |
| CD4+ T cell response to food | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $553,342 | November 18, 2024 | October 31, 2029 | JENKINS, MARC KEVIN | reporter.nih.gov |
| Beneficial effects of childhood vaccines for prevention of type 1 diabetes, autoimmune thyroid disease, and celiac disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2022 | $429,000 | September 6, 2021 | August 31, 2023 | KIM, CATHERINE | reporter.nih.gov |
| The Mechanistic Role of Gut Microbes and Gluten in Alopecia Areata | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2025 | $384,519 | August 15, 2025 | July 31, 2027 | DAI, ZHENPENG | reporter.nih.gov |
| Role of gut protists in celiac disease | NIH | National Institute of Allergy and Infectious Diseases | 2022 | $378,000 | August 15, 2022 | January 31, 2023 | HINTERLEITNER, REINHARD | reporter.nih.gov |
| Peptide-HLA-DQ2 biologics for antigen-specific therapy in Celiac Disease | NIH | National Institute of Allergy and Infectious Diseases | 2024 | $293,680 | June 20, 2024 | May 31, 2025 | GUO, HONGJIE | reporter.nih.gov |
| Refeyn TwoMP Mass Photometer with MassFluidix Microfluidic High Concentration (HC) Technology | NIH | Office of the Director, National Institutes of Health | 2025 | $288,212 | July 15, 2025 | July 14, 2026 | FERNANDEZ FLEISCHHAUER, DANIEL HUGO | reporter.nih.gov |
| Immune responses to ex vivo gluten challenge in children with celiac disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $265,500 | May 15, 2024 | April 30, 2026 | SILVESTER, JOCELYN ANNE | reporter.nih.gov |
| Novel approaches to dissect the genetic susceptibilities to celiac disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2025 | $249,000 | September 9, 2025 | August 31, 2027 | KONG, XIAO-FEI | reporter.nih.gov |
| Immunoprofiling for identifying biomarkers in celiac disease | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $197,240 | February 12, 2020 | January 31, 2024 | RIVERA-NIEVES, JESUS | reporter.nih.gov |
| A genetic and immunological investigation of JAK-STAT in the pathogenesis of Celiac Disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 | $165,456 | September 1, 2021 | April 30, 2026 | KONG, XIAO-FEI | reporter.nih.gov |
| Gluten peptide presentation in celiac disease: investigating the role of transglutaminase 2 using novel chemical probes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2023 | $80,072 | August 15, 2022 | August 14, 2024 | BESSER, HARRISON ANTHONY | reporter.nih.gov |
| Role of Gut Protist Derived Compounds on Dietary Antigen Presenting Dendritic Cells in Celiac Disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 | $48,974 | June 1, 2024 | April 28, 2025 | MEDINA-SANCHEZ, LUZMARIEL | reporter.nih.gov |
| Influence of Maternal IgA on Neonatal iNKT Cell Development and Gluten Sensitive Enteropathy. | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $41,778 | May 15, 2025 | May 14, 2028 | BALL, RYAN ALBERT WILLIAM | reporter.nih.gov |
Organizations
| Organization | Place | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|---|
| University of Chicago | Chicago, IL | 4 | $15.2 million | 0 | $0 |
| Stanford University | Stanford, CA | 4 | $5.6 million | 0 | $0 |
| Columbia University Health Sciences | New York, NY | 4 | $5.5 million | 0 | $0 |
| Immunogenics, LLC | Newport Beach, CA | 2 | $2.9 million | 0 | $0 |
| Massachusetts General Hospital | Boston, MA | 3 | $2.8 million | 0 | $0 |
| University of Pittsburgh at Pittsburgh | Pittsburgh, PA | 3 | $2.1 million | 0 | $0 |
| Baylor College of Medicine | Houston, TX | 1 | $2 million | 0 | $0 |
| Lunds Universitet | Lund | 1 | $1.8 million | 0 | $0 |
| Washington University | Saint Louis, MO | 1 | $1.8 million | 0 | $0 |
| Hackensack University Medical Center | Hackensack, NJ | 1 | $1.7 million | 0 | $0 |
| Evoq Therapeutics, Inc. | Ann Arbor, MI | 1 | $1.1 million | 0 | $0 |
| Ut Southwestern Medical Center | Dallas, TX | 2 | $910,824 | 0 | $0 |
| Boston Children's Hospital | Boston, MA | 2 | $845,619 | 0 | $0 |
| Children's Research Institute | Washington, DC | 1 | $793,000 | 0 | $0 |
| University of Maryland Baltimore | Baltimore, MD | 1 | $773,272 | 0 | $0 |
| Qrono, INC | Pittsburgh, PA | 1 | $599,945 | 0 | $0 |
| University of Virginia | Charlottesville, VA | 1 | $577,656 | 0 | $0 |
| University of Minnesota | Minneapolis, MN | 1 | $553,342 | 0 | $0 |
| University of Michigan at Ann Arbor | Ann Arbor, MI | 1 | $429,000 | 0 | $0 |
| Antiger Therapeutics Inc. | St Louis, MO | 1 | $293,680 | 0 | $0 |
| University of California, San Diego | La Jolla, CA | 1 | $197,240 | 0 | $0 |
| University of South Carolina at Columbia | Columbia, SC | 1 | $41,778 | 0 | $0 |
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|
| 2025 | 18 | $11,564,342 | 0 | $0 |
| 2024 | 15 | $9,165,232 | 0 | $0 |
| 2023 | 17 | $10,040,377 | 0 | $0 |
| 2022 | 18 | $8,718,097 | 0 | $0 |
| 2021 | 18 | $8,818,116 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
Updated November 3, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-02). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.